BMI View: Bangladesh's pharmaceutical export trajectory will be positive. Due to the tough competitive
domestic environment, local drugmakers have expanded successfully into frontier and emerging markets in
pursuit of commercial opportunities. With this as a foundat ..."
BMI View: Replicating India's success in the generic drugs sector will remain a challenge for Bangladesh.
The country's strategy of leveraging upon an extension of the patent waiver for least developed countries
presents limited opportunities, as many of these markets ..."
BMI View: While Bangladesh's ambitious goals for pharmaceutical exports are unlikely to be realised, the
sector will see modest growth ahead. Emerging markets such as Myanmar will be stable sources of demand
even as opportunities to export to the lucrative developed m ..."
BMI View: Sustained growth in Bangladesh's pharmaceutical and healthcare market will continue to
translate into commercial opportunities for drugmakers over the forecast period. A large generic medicine
segment will continue to account for the lion's share of the mark ..."
BMI View: Private consumption growth in Bangladesh will continue to gather momentum, contributing to
the pharmaceutical and healthcare sector expansion. In addition, the recent increase in the government
budget for health will translate in improved access to healthcar ..."
BMI View: Bangladesh's pharmaceutical and healthcare sector growth will continue to stand on robust
long-term fundamentals, including population growth, rising incomes, urbanisation and economic
expansion. Moreover, the country's efforts to increase drug manufacturing ..."
BMI View: The gap in the provision of medical services in Bangladesh provides a strong business
opportunity for private healthcare providers to make a foray into the market and establish a first mover
advantage. This is further affirmed by the persistent challenges fa ..."
BMI View: Chronic diseases will become a key healthcare challenge for Bangladesh over the next decade.
Driven by the country's ageing population, urbanisation and inadequate treatment of non-communicable
diseases, this represents an epidemiological transition that wil ..."
BMI View: We consider Bangladesh's commitment to another round of spending on the development of
healthcare, information technology, infrastructure, energy production, education, agriculture and food
security and transportation in fiscal year 2014/2015 as a sound inve ..."
BMI View: It is vital that Bangladesh's government works to improve the business environment for foreign
drugmakers. As Bangladesh's economy develops over the next 10 years, the country will experience more
cases of chronic diseases, such as obesity and diabetes. This ..."